Takeaways from the most recent news in the technology and policies shaping healthcare.
Insurers and the rules of getting paid: coverage, prior authorization, claims, denials, and the friction between health plans and the providers they reimburse.
CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.
Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.
Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.
Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.
Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.
Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.
ECG's managed care experts say academic health systems routinely undervalue their advanced services in payer contracts and must negotiate terms that reflect their true costs.
Why it matters: Academic health systems operate on thin margins, and payer contracts that ignore their higher costs threaten the research and safety-net care only they provide.
Health insurers are looking to agentic AI to orchestrate their existing systems rather than buy more standalone tools, Healthcare Dive reports.
Why it matters: If agentic AI can connect fragmented payer systems, it could cut the administrative costs that make health insurance slow and expensive.
Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.
Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.
CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.
Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.
A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.
Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.
Payer AI is accelerating claim denials and underpayments, fueling a multi-billion dollar cost to providers that some call the RCM Tax.
Why it matters: As insurers automate claim denials, providers that fail to modernize their revenue cycle risk losing significant revenue to rework and unappealed claims.
A federal judge dismissed Ballad Health's Medicare Advantage lawsuit against UnitedHealth, ordering the payment dispute into arbitration.
Why it matters: Arbitration clauses in payer contracts can quietly steer provider-insurer disputes out of court, shaping how health systems fight Medicare Advantage denials.
Medicare Advantage plans are refocusing on the post-discharge period to reduce readmissions and protect Star Ratings.
Why it matters: Star Ratings drive billions in bonus payments and enrollment, and better care transitions are becoming a key way plans defend those scores.
KFF Health News details how vertical integration across hospitals, insurers, and pharmacies steers patients toward higher-priced care and inflates their bills.
Why it matters: As a handful of integrated companies control care, coverage, and drugs, patients face higher costs with little visibility into why.
Walmart will send employees to 17 health systems in 2026 for complex care through its Centers of Excellence program, covering treatment and travel at no cost.
Why it matters: As one of the largest U.S. employers, Walmart's decision to steer workers to vetted providers pressures health systems to prove quality and reshapes how expensive care gets purchased.
UnitedHealth Group is facing an IRS probe into transfers involving foreign subsidiaries that may have lowered its US taxes, STAT News reports.
Why it matters: A tax dispute at the largest US health insurer could add to mounting financial and regulatory pressure on a company central to the healthcare system.
Medicare Advantage plans are treating the first 24 hours after hospital discharge as a make-or-break window for reducing readmissions and defending their star ratings.
Why it matters: Star ratings drive billions in CMS bonus payments and member enrollment, making post-discharge care a direct lever on plan revenue.
Providence will fully exit the insurance business, shutting down Providence Health Plan after a Medicare Advantage deal with a national insurer fell through.
Why it matters: It underscores how hard Medicare Advantage economics have become, pushing even large health systems out of owning insurance plans.
CVS Caremark named 25-year company veteran Keith Reynolds as chief growth officer as Chief Sales Officer Jim Fowler retires.
Why it matters: CVS Caremark is one of the largest PBMs in the US, and its growth strategy shapes drug costs for millions as regulators scrutinize the industry.
A year after HR 1, Medicaid faces looming eligibility checks and work requirements, with six states serving as bellwethers for coverage and financial impact.
Why it matters: Medicaid churn drives uncompensated care and margin pressure for hospitals while reshaping insurer enrollment ahead of 2027 rule changes.
UnitedHealthcare is adding reimbursement limits on five lab test categories across its major plan lines, with most policies effective Sept. 1.
Why it matters: New payer limits mean more denials and documentation burden for labs and physicians ordering these tests.
A handful of insurers are exiting or scaling back Medicare Advantage markets as rising medical costs, federal cuts, and star-rating disputes pressure profits.
Why it matters: Insurer pullbacks mean fewer plan choices for seniors and shifting payer dynamics for hospitals and medical groups.